as on
| Source : NSE
as on August 19, 2025 at 4:01 PM IST
Day's Low
Day's High
1.10%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
31.35%
Downside
58.40%
Upside
Market Stats | |
Previous Close | ₹100.49 |
Open | ₹102.45 |
Volume | 39.32K |
Upper Circuit | ₹105.51 |
Lower Circuit | ₹95.46 |
Day's Low | ₹99 |
Day's High | ₹102.45 |
52 Week Low | ₹68.72 |
52 Week High | ₹158.56 |
Returns % | |
1 Month Return | -5.21 % |
3 Month Return | + 39.53 % |
1 Year Return | -22.78 % |
3 Year Return | + 60.78 % |
5 Year Return | + 160.67 % |
Check Ind-Swift Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹738.47 Cr
Return on Equity (ROE)
18.99
PE Ratio (TTM)
3
Return on capital employed (ROCE)
20.55
Industry PE ratio
43.29
Beta (LTM)
0.56
P/B Ratio
0.63
Dividend Yield
0PEG Ratio
-0.05
Quarterly Earnings Growth YOY
756.44
EPS (TTM)
71.33
Sector
Pharmaceuticals
Book Value
157.64
Technical Analysis
Bearish
View Technical Analysis
Track how Ind-Swift Laboratories Ltd P/E has moved over time to understand its valuation trends.
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.00x)
August 18, 2025
Industry (43.29x)
August 18, 2025
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.00x
Get the annual and quarterly financial summary of Ind-Swift Laboratories Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd’s net profit jumped 832.98% since last year same period to ₹8.77Cr in the Q1 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -96.05% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.97%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ind-Swift Laboratories Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 37.72% | 2.57 | |
Foreign Institutions | 16.68% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.84% | ||
Others | 0.75% |
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 738.47 | 32.13% | 0.51 | 421 | 1,280 | |
NA | 728.86 | 64.23% | 0.58 | 13 | 154 | |
NA | 5.40 | -7.32% | 0.00 | -2 | 16 | |
NA | 322.13 | 162.03% | 0.00 | -4 | 39 | |
BUY | 17,104.75 | 14.68% | 0.50 | 371 | 1,200 |
Latest news and events in one place to help you make informed investing decisions in Ind-Swift Laboratories Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, INDSWFTLAB stock has moved up by 39.5%
Promoter Holding Up
Promoters have increased holdings from 36.77% to 37.72% in Aug 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 32.0% return, outperforming this stock by 54.8%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.7% return, outperforming this stock by 75.9%
FII Holding Down
Foreign Institutions have decreased holdings from 16.99% to 16.68% in Aug 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 358.57 Cr → 167.32 Cr (in ₹), with an average decrease of 53.3% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 222.27 Cr → 8.77 Cr (in ₹), with an average decrease of 96.1% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 45.47% to 44.84% in Aug 2025 quarter
Organisation | Ind-Swift Laboratories Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
CEO | N R Munjal |
E-voting on shares | Click here to vote |
Ind-Swift Laboratories Ltd share price today stands at ₹100.1, Open: ₹102.45, Previous Close: ₹100.49, High: ₹102.45, Low: ₹99, 52 Week High: ₹158.56, 52 Week Low: ₹68.72 as on .
To buy Ind-Swift Laboratories Ltd shares, you need to follow these steps:
Today's traded volume of Ind-Swift Laboratories Ltd is 39.32K. Which means that 39.32K shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Ind-Swift Laboratories Ltd is ₹738.47 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Ind-Swift Laboratories Ltd’s 52 week high is ₹158.56 and 52 week low is ₹68.72. The current share price of Ind-Swift Laboratories Ltd is ₹100.1, which is -36.87% down from its 52 week high and 45.66% up from its 52 week low.